Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice

Psychopharmacology

Volumn 232, Issue 12, 2015, Pages 2157-2167

  Aliczki, Mano ^a   Varga, Zoltan Kristof ^a   Balogh, Zoltan ^a   Haller, Jozsef ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

2 arachidonoylglycerol; Aggression; AM251; CB1R; Corticosterone; Endocannabinoid; JZL184; Metyrapone; Monoacilglycerol lipase; Social behavior

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,3 BENZODIOXOLE DERIVATIVE; 2-ARACHIDONYLGLYCEROL; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ACYLGLYCEROL; ACYLGLYCEROL LIPASE; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CORTICOSTERONE; ENDOCANNABINOID; ENZYME INHIBITOR; METYRAPONE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

AGGRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

AGGRESSION; AGONISTIC BEHAVIOR; ANIMALS; ARACHIDONIC ACIDS; BENZODIOXOLES; CANNABINOID RECEPTOR AGONISTS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; MALE; METYRAPONE; MICE; MONOACYLGLYCEROL LIPASES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION;

EID: 84939946944     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3846-1     Document Type: Article

References (40)

1. Aliczki M, Balogh Z, Tulogdi A, Haller J (2012) The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature. Behav Pharmacol 23:348-357
2. Aliczki M, Zelena D, Mikics E, Varga ZK, Pinter O, Bakos NV, Varga J, Haller J (2013) Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice. Horm Behav 63:752-758
3. Arndt SS, Laarakker MC, van Lith HA, van der Staay FJ, Gieling E, Salomons AR, van't Klooster J, Ohl F (2009) Individual housing of mice - impact on behaviour and stress responses. Physiol Behav 97:385-393
4. Benton D, Brain PF (1981) Behavioral and adrenocortical reactivity in female mice following individual or group housing. Dev Psychobiol 14:101-107
5. Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R, Ozaita A (2011) Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry 70:479-486
6. Capanna E, Corti M, Mainardi D, Parmigiani S, Brain PF (1984) Karyotype and intermale aggression in wild house mice: ecology and speciation. Behav Genet 14:195-208
7. Cassano T, Gaetani S, Macheda T, Laconca L, Romano A, Morgese MG, Cimmino CS, Chiarotti F, Bambico FR, Gobbi G, Cuomo V, Piomelli D (2011) Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacol (Berl) 214:465-476
8. Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573-580
9. Cruz AP, Frei F, Graeff FG (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49:171-176
10. Fernandez Espejo E (1997) Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86:105-112
11. File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
12. Haller J, Varga B, Ledent C, Freund TF (2004) CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 15:299-304
13. Haller J, Matyas F, Soproni K, Varga B, Barsy B, Nemeth B, Mikics E, Freund TF, Hajos N (2007) Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci 25:2445-2456
14. Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G (2009) The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol Sci 30:484-493
15. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavon FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5:37-44
16. Manduca A, Servadio M, Campolongo P, Palmery M, Trabace L, Vanderschuren LJ, Cuomo V, Trezza V (2014) Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur Neuropsychopharmacol 24:1337-1348
17. Miczek KA (1978) delta9-tetrahydrocannabinol: antiaggressive effects in mice, rats, and squirrel monkeys. Science 199:1459-1461
18. Mikics E, Kruk MR, Haller J (2004) Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats. Psychoneuroendocrinology 29:618-635
19. Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG (2008) An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Psychopharmacology 200:333-346
20. Moreira FA, Grieb M, Lutz B (2009) Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab 23:133-144
21. Navarro JF, Buron E, Martin-Lopez M (2006) Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice. Psicothema 18:100-104
22. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514-536
23. Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease - successes and failures. FEBS J 280:1918-1943
24. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
25. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884
26. Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12:21-38
27. Poshivalov VP (1980) The integrity of the social hierarchy in mice following administration of psychotropic drugs. Br J Pharmacol 70:367-373
28. Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621-634
29. Rodriguez-Arias M, Navarrete F, Daza-Losada M, Navarro D, Aguilar MA, Berbel P, Minarro J, Manzanares J (2013) CB1 cannabinoid receptor-mediated aggressive behavior. Neuropharmacology 75C:172-180
30. Sciolino NR, Zhou W, Hohmann AG (2011) Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol Res 64:226-234
31. Tambaro S, Bortolato M (2012) Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discov 7:25-40
32. Toth M, Mikics E, Tulogdi A, Aliczki M, Haller J (2011) Post-weaning social isolation induces abnormal forms of aggression in conjunction with increased glucocorticoid and autonomic stress responses. Horm Behav 60:28-36
33. Valverde O (2005) Participation of the cannabinoid system in the regulation of emotional-like behaviour. Curr Pharm Des 11:3421-3429
34. van Ree JM, Niesink RJ, Nir I (1984) delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters. Psychopharmacol (Berl) 84:561-565
35. Wall PM, Blanchard RJ, Yang M, Blanchard DC (2003) Infralimbic D2 receptor influences on anxiety-like behavior and active memory/attention in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 27:395-410
36. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678-682
37. You IJ, Jung YH, Kim MJ, Kwon SH, Hong SI, Lee SY, Jang CG (2012) Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT(1)A, GABA(A), and NMDA receptors. Neuropharmacology 62(2):1034-1043
38. Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S (2011) Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 5:57
39. Zhao P, Abood ME (2013) GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors. Life Sci 92:453-457
40. Zygmunt PM, Ermund A, Movahed P, Andersson DA, Simonsen C, Jonsson BA, Blomgren A, Birnir B, Bevan S, Eschalier A, Mallet C, Gomis A, Hogestatt ED (2013) Monoacylglycerols activate TRPV1 - a link between phospholipase C and TRPV1. PLoS One 8:e81618